购物车
全部删除
您的购物车当前为空
GPX4-IN-6 是一种小分子共价 GPX4 抑制剂(IC50: 0.12 μM),具有抗肿瘤活性。GPX4-IN-6 可促使铁死亡,用于治疗=和预防三阴性乳腺癌 (TNBC)。


为众多的药物研发团队赋能,
让新药发现更简单!
GPX4-IN-6 是一种小分子共价 GPX4 抑制剂(IC50: 0.12 μM),具有抗肿瘤活性。GPX4-IN-6 可促使铁死亡,用于治疗=和预防三阴性乳腺癌 (TNBC)。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 283 | 现货 | |
| 5 mg | ¥ 663 | 现货 | |
| 10 mg | ¥ 997 | 现货 | |
| 25 mg | ¥ 1,890 | 现货 | |
| 50 mg | ¥ 2,970 | 现货 | |
| 100 mg | ¥ 4,820 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 728 | 现货 |
GPX4-IN-6 相关产品
| 产品描述 | GPX4-IN-6 is a small molecule covalent GPX4 inhibitor (IC50: 0.12 μM) with antitumour activity.GPX4-IN-6 induces ferroptosis and is used for the treatment= and prevention of triple negative breast cancer (TNBC). |
| 靶点活性 | GPX4:0.13 μM |
| 分子量 | 426.23 |
| 分子式 | C18H17BrFNO5 |
| CAS No. | 2922824-07-3 |
| Smiles | O=C(N(C1=CC=C2OCCOC2=C1)C3=CC(OC)=C(F)C(OC)=C3)CBr |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 30 mg/mL (70.38 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.69 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容